WCN26-7699 B-CELL–TARGETED THERAPY FOR IDIOPATHIC NEPHROTIC SYNDROME: RESULTS OF THE PHASE III, GLOBAL, MULTICENTER INSHORE TRIAL ASSESSING OBINUTUZUMAB VS MYCOPHENOLATE MOFETIL
Julien Hogan, Larry A. Greenbaum, Kandai Nozu, Malgorzata Mizerska-Wasiak et autres
1 citationKidney International Reports